4153 logo

DIVA Laboratories, Ltd.TPEX:4153 Stock Report

Market Cap NT$2.4b
Share Price
NT$41.30
My Fair Value
AN
AnalystConsensusTarget
NT$17
138.6% overvalued intrinsic discount
1Y-10.3%
7D-0.4%
Portfolio Value
View

DIVA Laboratories, Ltd.

TPEX:4153 Stock Report

Market Cap: NT$2.4b

DIVA Laboratories (4153) Stock Overview

Engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. More details

4153 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends1/6

4153 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

DIVA Laboratories, Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for DIVA Laboratories
Historical stock prices
Current Share PriceNT$41.30
52 Week HighNT$55.80
52 Week LowNT$31.30
Beta-0.0065
1 Month Change1.72%
3 Month Change-1.67%
1 Year Change-10.31%
3 Year Change54.10%
5 Year Change46.30%
Change since IPO150.63%

Recent News & Updates

Recent updates

Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

Feb 28
Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Dec 27
DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Nov 30
Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Shareholder Returns

4153TW ElectronicTW Market
7D-0.4%5.0%0.3%
1Y-10.3%6.1%6.6%

Return vs Industry: 4153 underperformed the TW Electronic industry which returned -1.5% over the past year.

Return vs Market: 4153 underperformed the TW Market which returned 2.4% over the past year.

Price Volatility

Is 4153's price volatile compared to industry and market?
4153 volatility
4153 Average Weekly Movement2.6%
Electronic Industry Average Movement5.1%
Market Average Movement4.6%
10% most volatile stocks in TW Market7.6%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 4153 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4153's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995n/aShuqi Liuwww.diva.com.tw

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers video solutions.

DIVA Laboratories, Ltd. Fundamentals Summary

How do DIVA Laboratories's earnings and revenue compare to its market cap?
4153 fundamental statistics
Market capNT$2.42b
Earnings (TTM)NT$88.94m
Revenue (TTM)NT$859.02m
27.2x
P/E Ratio
2.8x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4153 income statement (TTM)
RevenueNT$859.02m
Cost of RevenueNT$592.57m
Gross ProfitNT$266.45m
Other ExpensesNT$177.50m
EarningsNT$88.94m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.52
Gross Margin31.02%
Net Profit Margin10.35%
Debt/Equity Ratio0%

How did 4153 perform over the long term?

See historical performance and comparison

Dividends

4.8%
Current Dividend Yield
132%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/01 11:23
End of Day Share Price 2025/08/01 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DIVA Laboratories, Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
Hsiu Chi LinMasterlink Securities Corp.